$STLN News

Oncology Institute Q2 Earnings Call Highlights

Starling Oncology shares are trading higher after the company reported a year-over-year decrease in Q2 loss per share and increase in sales results.

Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY

Starling Oncology, Inc. (STLN) Q2 2026 Earnings Call Transcript

Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10?

BTIG Maintains Buy on Oncology Institute, Raises Price Target to $9

The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity

Why Oncology Institute’s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus

Lake Street Initiates Coverage On Oncology Institute with Buy Rating, Announces Price Target of $10

The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?

Needham Maintains Buy on Oncology Institute, Raises Price Target to $7

How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%

BTIG Maintains Buy on Oncology Institute, Raises Price Target to $8

The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference

Oncology Institute Says In Follow Up To Nov 2025 Disclosure Of A Cybersecurity Incident, Says A Software Service Provider Detected Unauthorized Access; Vendor Had Unauthorized Access To Information Systems Including Patient Data; Cybersecurity Incident Believed To Affect Other Healthcare Providers; Patient Portal Established; Operations Continue In All Material Respects Since Incident Detection

The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference

The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00

Oncology Institute Q1 Earnings Call Highlights

The Oncology Institute, Inc. Q1 2026 Earnings Call Summary